Sonoma Pharmaceuticals
SNOA
16 hedge funds and large institutions have $1.42M invested in Sonoma Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 1 reducing their positions, and 6 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 1
0% more capital invested
Capital invested by funds: $1.42M → $1.42M (+$3K)
24% less funds holding
Funds holding: 21 → 16 (-5)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$86.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$51K |
| 4 |
GW
GW & Wade
Wellesley,
Massachusetts
|
+$39.1K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$26.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$78K |
| 2 |
Morgan Stanley
New York
|
-$33.2K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$26K |
| 4 |
Barclays
London,
United Kingdom
|
-$18K |
| 5 |
FANJ
Financial Architects (New Jersey)
Marlton,
New Jersey
|
-$9K |
SNOA Hedge Fund Activity: Q3 2015 in Review
16 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q3 2015, worth a combined $1.42M — up 0.21% from $1.42M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SNOA and 1 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 8 added.
The largest buyer was Vanguard Group, adding an estimated $86.5K. The largest seller was Jane Street, exiting entirely with an estimated $78K sold.
- 16 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q3 2015, down from 21 in Q2 2015.
- Funds reported $1.42M of Sonoma Pharmaceuticals stock for Q3 2015, up 0.21% quarter-over-quarter.
- 1 fund opened new Sonoma Pharmaceuticals positions in Q3 2015 and 6 closed out, a net change of -5 holders.
- The largest Sonoma Pharmaceuticals buyer in Q3 2015 was Vanguard Group, an estimated $86.5K added.
- The largest Sonoma Pharmaceuticals seller in Q3 2015 was Jane Street, an estimated $78K sold.
Based on aggregated 13F filings for Q3 2015.